Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Leprfa/IzmDmcr rats with metabolic syndrome

Author: Kagota Satomi   Tada Yukari   Nejime Namie   Nakamura Kazuki   Kunitomo Masaru   Shinozuka Kazumasa  

Publisher: NRC Research Press

ISSN: 1205-7541

Source: Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.5, 2011-05, pp. : 355-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content